Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function

Yilmaz, BÜLENT; Kelekci, S; Savan, K; Oral, H; Mollamahmutoglu, L

doi:10.1016/j.fertnstert.2005.09.018

Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function

Atıf İçin Kopyala

Yilmaz B., Kelekci S., Savan K., Oral H., Mollamahmutoglu L.

FERTILITY AND STERILITY, cilt.85, sa.3, ss.783-786, 2006 (SCI-Expanded)

Yayın Türü: Makale / Editöre Mektup
Cilt numarası: 85 Sayı: 3
Basım Tarihi: 2006
Doi Numarası: 10.1016/j.fertnstert.2005.09.018
Dergi Adı: FERTILITY AND STERILITY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.783-786
Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

In a randomized prospective study, 125 women with World Health Organization class II anovulation received 50 mg of clomiphene citrate alone (group A, n = 65) or 50 mg of clomiphene citrate plus hCG (group B, n = 60) in a total of 125 cycles during natural intercourse-advised cycles. There were no statistically significant differences between groups regarding pregnancy outcomes and midluteal P levels, but luteal phase length was longer in group A.